Anti-RUNX2 Antibody
Referencia MBS821171-0,1mL
embalaje : 0.1mL
Marca : MyBiosource
RUNX2 Antibody – Rabbit Polyclonal
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS821171MBS821171 is an antibody targeting RUNX2. Reactive in Human, Mouse, Rat, Chicken. Host: Rabbit. Rabbit polyclonal antibody to RUNX2 More details
Product Overview
Online Datasheet in PDFProduct Name
RUNX2, Polyclonal Antibody
Full Product Name
Anti-RUNX2 Antibody
Product Gene Name
anti-RUNX2 antibody
Product Synonym Names
AML3; CBFA1; OSF2; PEBP2A; Runt-related transcription factor 2; Acute myeloid leukemia 3 protein; Core-binding factor subunit alpha-1; CBF-alpha-1; Oncogene AML-3; Osteoblast-specific transcription factor 2; OSF-2; Polyomavirus enhancer-binding protein 2 alpha A subunit; PEA2-alpha A; PEBP2-alpha A; SL3-3 enhancer factor 1 alpha A subunit; SL3/AKV core-binding factor alpha A subunit
Clonality
Polyclonal
Host
Rabbit
Species Reactivity
Human, Mouse, Rat, Chicken
Form/Format
Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.
Purity/Purification
The antibody was purified by immunogen affinity chromatography.
Specificity
Recognizes endogenous levels of RUNX2 protein.
Preparation and Storage
Upon delivery aliquot and store at -20°C. Avoid freeze/thaw cycles.
Antibody/Peptide Pairs
RUNX2 peptide (MBS823984) is used for blocking the activity of RUNX2 antibody (MBS821171)
Applications Tested/Suitable for anti-RUNX2 antibody
Western Blot (WB)
Application Notes for anti-RUNX2 antibody
WB (1/500 - 1/1000)
Immunohistochemistry (IHC) of anti-RUNX2 antibody
Immunohistochemical analysis of RUNX2 staining in human brain formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
Other Notes
Small volumes of anti-RUNX2 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for RUNX2. It may not necessarily be applicable to this product.
NCBI Official Full Name
runt-related transcription factor 2 isoform b
NCBI Official Synonym Full Names
runt-related transcription factor 2
NCBI Official Symbol
RUNX2
NCBI Official Synonym Symbols
CCD; AML3; CCD1; CLCD; OSF2; CBFA1; OSF-2; PEA2aA; PEBP2aA; CBF-alpha-1
UniProt Protein Name
Runt-related transcription factor 2
UniProt Synonym Protein Names
Acute myeloid leukemia 3 protein; Core-binding factor subunit alpha-1; CBF-alpha-1; Oncogene AML-3; Osteoblast-specific transcription factor 2; OSF-2; Polyomavirus enhancer-binding protein 2 alpha A subunit; PEA2-alpha A; PEBP2-alpha A; SL3-3 enhancer factor 1 alpha A subunit; SL3/AKV core-binding factor alpha A subunit
Protein Family
Runt-related transcription factor
UniProt Gene Name
RUNX2
UniProt Synonym Gene Names
AML3; CBFA1; OSF2; PEBP2A; CBF-alpha-1; OSF-2; PEA2-alpha A; PEBP2-alpha A
UniProt Entry Name
RUNX2_HUMAN
NCBI Protein Information
runt-related transcription factor 2; PEA2-alpha A; PEBP2-alpha A; oncogene AML-3; acute myeloid leukemia 3 protein; SL3-3 enhancer factor 1 alpha A subunit; osteoblast-specific transcription factor 2; SL3/AKV core-binding factor alpha A subunit; core-binding factor, runt domain, alpha subunit 1; polyomavirus enhancer-binding protein 2 alpha A subunit
NCBI Summary for RUNX2
This gene is a member of the RUNX family of transcription factors and encodes a nuclear protein with an Runt DNA-binding domain. This protein is essential for osteoblastic differentiation and skeletal morphogenesis and acts as a scaffold for nucleic acids and regulatory factors involved in skeletal gene expression. The protein can bind DNA both as a monomer or, with more affinity, as a subunit of a heterodimeric complex. Mutations in this gene have been associated with the bone development disorder cleidocranial dysplasia (CCD). Transcript variants that encode different protein isoforms result from the use of alternate promoters as well as alternate splicing. [provided by RefSeq, Jul 2008]
Show more UniProt Comments for RUNX2
AML3: Transcription factor involved in osteoblastic differentiation and skeletal morphogenesis. Essential for the maturation of osteoblasts and both intramembranous and endochondral ossification. CBF binds to the core site, 5'- PYGPYGGT-3', of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers, osteocalcin, osteopontin, bone sialoprotein, alpha 1(I) collagen, LCK, IL-3 and GM-CSF promoters. In osteoblasts, supports transcription activation: synergizes with SPEN/MINT to enhance FGFR2-mediated activation of the osteocalcin FGF-responsive element (OCFRE). Inhibits KAT6B-dependent transcriptional activation. Interaction with SATB2 results in enhanced DNA binding and transactivation by these transcription factors. Heterodimer of an alpha and a beta subunit. Interacts with HIVEP3 and HIPK3. The alpha subunit binds DNA as a monomer and through the Runt domain. DNA-binding is increased by heterodimerization. Interacts with XRCC6 (Ku70) and XRCC5 (Ku80). Interacts with KAT6A and KAT6B. Binds to cyclin B1 CCNB1. Interacts with DDX5. Specifically expressed in osteoblasts. 3 isoforms of the human protein are produced by alternative splicing.
Protein type: Transcription factor; DNA-binding
Chromosomal Location of Human Ortholog: 6p21
Cellular Component: nucleoplasm; transcription factor complex; nuclear chromatin; cytoplasm
Molecular Function: protein domain specific binding; protein binding; bHLH transcription factor binding; chromatin binding; transcription factor activity; ATP binding
Biological Process: embryonic forelimb morphogenesis; transcription initiation from RNA polymerase II promoter; ossification; positive regulation of transcription, DNA-dependent; cell maturation; regulation of fibroblast growth factor receptor signaling pathway; stem cell differentiation; embryonic cranial skeleton morphogenesis; chondrocyte development; odontogenesis of dentine-containing teeth; osteoblast development; BMP signaling pathway; osteoblast differentiation; positive regulation of osteoblast differentiation; positive regulation of chondrocyte differentiation; negative regulation of smoothened signaling pathway; positive regulation of cell proliferation; gene expression; negative regulation of transcription, DNA-dependent; T cell differentiation; osteoblast fate commitment; regulation of odontogenesis of dentine-containing teeth; endochondral ossification
Disease: Metaphyseal Dysplasia With Maxillary Hypoplasia With Or Without Brachydactyly; Cleidocranial Dysplasia
Show more Protein type: Transcription factor; DNA-binding
Chromosomal Location of Human Ortholog: 6p21
Cellular Component: nucleoplasm; transcription factor complex; nuclear chromatin; cytoplasm
Molecular Function: protein domain specific binding; protein binding; bHLH transcription factor binding; chromatin binding; transcription factor activity; ATP binding
Biological Process: embryonic forelimb morphogenesis; transcription initiation from RNA polymerase II promoter; ossification; positive regulation of transcription, DNA-dependent; cell maturation; regulation of fibroblast growth factor receptor signaling pathway; stem cell differentiation; embryonic cranial skeleton morphogenesis; chondrocyte development; odontogenesis of dentine-containing teeth; osteoblast development; BMP signaling pathway; osteoblast differentiation; positive regulation of osteoblast differentiation; positive regulation of chondrocyte differentiation; negative regulation of smoothened signaling pathway; positive regulation of cell proliferation; gene expression; negative regulation of transcription, DNA-dependent; T cell differentiation; osteoblast fate commitment; regulation of odontogenesis of dentine-containing teeth; endochondral ossification
Disease: Metaphyseal Dysplasia With Maxillary Hypoplasia With Or Without Brachydactyly; Cleidocranial Dysplasia
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with anti-RUNX2 antibody
| Reference Product | PubMed Publications |
|---|---|
| SOX9 antibody | >240 publications with RUNX2 and SOX9 |
| SP7 antibody | >137 publications with RUNX2 and SP7 |
| MSX2 antibody | >131 publications with RUNX2 and MSX2 |
| SMAD3 antibody | >44 publications with RUNX2 and SMAD3 |
| BGLAP antibody | >41 publications with RUNX2 and BGLAP |
| CBFB antibody | >30 publications with RUNX2 and CBFB |
| SMAD4 antibody | >29 publications with RUNX2 and SMAD4 |
| RB1 antibody | >7 publications with RUNX2 and RB1 |
| EP300 antibody | >6 publications with RUNX2 and EP300 |
| UBC antibody | >1 publications with RUNX2 and UBC |
Pathways associated with anti-RUNX2 antibody
| Products by Pathway | Pathway Diagram |
|---|---|
| Androgen Receptor Signaling Pathway antibodies | Androgen Receptor Signaling Pathway Diagram |
| BMP Signalling And Regulation Pathway antibodies | BMP Signalling And Regulation Pathway Diagram |
| Endochondral Ossification Pathway antibodies | Endochondral Ossification Pathway Diagram |
| FGF Signaling Pathway antibodies | FGF Signaling Pathway Diagram |
| Gene Expression Pathway antibodies | Gene Expression Pathway Diagram |
| Generic Transcription Pathway antibodies | Generic Transcription Pathway Diagram |
| Interleukin-11 Signaling Pathway antibodies | Interleukin-11 Signaling Pathway Diagram |
| Notch-mediated HES/HEY Network Pathway antibodies | Notch-mediated HES/HEY Network Pathway Diagram |
| Regulation Of Nuclear SMAD2/3 Signaling Pathway antibodies | Regulation Of Nuclear SMAD2/3 Signaling Pathway Diagram |
| Regulation Of Retinoblastoma Protein Pathway antibodies | Regulation Of Retinoblastoma Protein Pathway Diagram |
Diseases associated with anti-RUNX2 antibody
| Disease Name | Pubmed Publications |
|---|---|
| Cleidocranial Dysplasia Antibodies | >157 publications with RUNX2 and Cleidocranial Dysplasia |
| Craniofacial Abnormalities Antibodies | >149 publications with RUNX2 and Craniofacial Abnormalities |
| Necrosis Antibodies | >109 publications with RUNX2 and Necrosis |
| Hypertrophy Antibodies | >107 publications with RUNX2 and Hypertrophy |
| Inflammation Antibodies | >94 publications with RUNX2 and Inflammation |
| Cardiovascular Diseases Antibodies | >91 publications with RUNX2 and Cardiovascular Diseases |
| Kidney Diseases Antibodies | >45 publications with RUNX2 and Kidney Diseases |
| Breast Neoplasms Antibodies | >45 publications with RUNX2 and Breast Neoplasms |
| Prostatic Neoplasms Antibodies | >42 publications with RUNX2 and Prostatic Neoplasms |
| Neoplasm Invasiveness Antibodies | >23 publications with RUNX2 and Neoplasm Invasiveness |
Organs/Tissues associated with anti-RUNX2 antibody
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Bone Antibodies | >2730 publications with RUNX2 and Bone |
| Bone Marrow Antibodies | >643 publications with RUNX2 and Bone Marrow |
| Mouth Antibodies | >210 publications with RUNX2 and Mouth |
| Muscle Antibodies | >207 publications with RUNX2 and Muscle |
| Embryonic Tissue Antibodies | >203 publications with RUNX2 and Embryonic Tissue |
| Heart Antibodies | >57 publications with RUNX2 and Heart |
| Brain Antibodies | >43 publications with RUNX2 and Brain |
| Liver Antibodies | >42 publications with RUNX2 and Liver |
| Skin Antibodies | >35 publications with RUNX2 and Skin |
| Lung Antibodies | >35 publications with RUNX2 and Lung |
Usted podría estar interesado también en los siguientes productos:
Referencia
Descripción
Cond.
Precio Sin IVA



